Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence. (2019)

First Author: Grüschow S
Attributed to:  Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkz676

PubMed Identifier: 31392987

Publication URI: http://europepmc.org/abstract/MED/31392987

Type: Journal Article/Review

Volume: 47

Parent Publication: Nucleic acids research

Issue: 17

ISSN: 0305-1048